š š Sun Pharmaceutical Industries on Tuesday reported a consolidated net profit of ā¹1,387.48 crore for the quarter ended June 30, 2019.
The company had posted a profit of ā¹1,057.29 crore for the corresponding period of the previous fiscal, Sun Pharma said in a filing to BSE.
Total revenue from operations for the quarter under review stood at ā¹8,374.36 crore. It was ā¹7,224.17 crore for the same period a year ago.
"Pola Pharma lnc Japan became a step-down subsidiary of the company with effect from January 1, 20l9. Accordingly, the results for the quarter include results of Pola Pharma Inc, and hence are not comparable with quarter ended June 30, 2018," the company said.
NEWS AND PIC CREDIT
Regards,
AMIT KONAR
Proprietor
KONAR TRADE TALK ā¢